Gimme Care vs Hims
Gimme Care costs $69 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gimme Care
Best for: semaglutide at $130/month, 39% below the typical price
Visit Gimme Care →
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between Gimme Care and Hims, the first difference is cost: Gimme Care is $69 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gimme Care leads our six-part score, 8.7 to 6.8. One of the two has an FDA warning letter on record, covered below.
Gimme Care vs Hims price
Gimme Care is the cheaper way in: $130 a month against $199 a month at Hims. That is $69 less each month (35% lower), or about $828 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Gimme Care ($130 a month vs $199 a month); tirzepatide is cheaper at Gimme Care ($163 a month vs $299 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Gimme Care prices compounded injections, while Hims prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Gimme Care lists 51 states, and Hims lists 50 states.
They overlap in 50 states. Gimme Care alone covers District of Columbia.
Pricing
Gimme Care
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
Gimme Care's price also covers the clinician visit and shipping, which Hims does not claim.
Gimme Care is silent on lab work and coaching.
Hims is silent on shipping and lab work.
Gimme Care
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Gimme Care scores 8.7 and Hims 6.8 out of 10.
Gimme Care is stronger on value (8.1 vs 3.0), trust & safety (8.5 vs 7.0) and support (7.0 vs 3.0).
Effectiveness, user experience and accessibility are within half a point.
Gimme Care
8.7/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Gimme Care has no FDA warning letter on record with us.
Features & Coverage
| Feature | Gimme Care | Hims |
|---|---|---|
| Starting Price | ✓$130/mo | $199/mo |
| Features | ✓5 features | 2 features |
| States Available | ✓51 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Gimme Care
Gimme Care sells compounded semaglutide at $130-$160/mo and compounded tirzepatide at $163-$199/mo, microdose options included. It is LegitScript verified, available in all 50 states plus DC, with no membership fees.
Read our full Gimme Care review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
Gimme Care
What we like
- Semaglutide costs $130 a month, 29% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $163 a month, 35% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Gimme Care
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Gimme Care wins this one, 8.7 to 6.8, above all for semaglutide at $130/month, 39% below the typical price. It also costs $69 less each month than Hims. Hims fits better if knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC is your priority.
Choose Gimme Care if…
You want semaglutide at $130/month, 39% below the typical price and an opening price near $130 a month.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Gimme Care vs Hims: FAQ
Close alternatives to Gimme Care and Hims
- Gimme Care vs Bioverse
- Gimme Care vs Alternate Health Club
- Gimme Care vs DoctorAdam
- Gimme Care vs Longevixx
- Hims vs Hers
- Hims vs Noom
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.